BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+1.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.1B
AUM Growth
+$7.1B
(+0.85%)
Cap. Flow
-$139M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
75.68%
Holding
101
New
15
Increased
16
Reduced
17
Closed
6
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$81.5M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$56.4M |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$27.2M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$15.3M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$13.8M |
Top Sells
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
$220M |
| 2 |
Gilead Sciences
GILD
|
$51.8M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
$30.8M |
| 4 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
$24.5M |
| 5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$22.7M |
Sector Composition
| 1 | Healthcare | 44.38% |
